Naproxen Mepha 250 mg
Naproxen Mepha 250 mg is a medicine authorised by Swissmedic under authorisation number 51480. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 February 1994 and the authorisation is valid without a time limit. ATC code M01AE02 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 51480 |
|---|---|
| Name | Naproxen Mepha 250 mg |
| Full name | Naproxen Mepha 250 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AE02 |
| First authorisation | 18 February 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Naproxen Mepha 250 mg, Filmtabletten | B | 18 February 1994 |
| 2 | Naproxen Mepha 500 mg, Filmtabletten | B | 18 February 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 20 | Tablette(n) | M01AE02 | 07.10.1. | B |
| 31 | 10 | Tablette(n) | M01AE02 | 07.10.1. | B |
| 58 | 20 | Tablette(n) | M01AE02 | 07.10.1. | B |
| 66 | 50 | Tablette(n) | M01AE02 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Naproxen Mepha 250 mg authorised in Switzerland?
Yes. Naproxen Mepha 250 mg is authorised by Swissmedic under authorisation number 51480, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Naproxen Mepha 250 mg have?
Naproxen Mepha 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Naproxen Mepha 250 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.